Successfully Resected Cardiac Metastatic Melanoma in a Lifesaving Cardiac Surgery: A Case Report
Keywords:cardiac melanoma, emergency surgery, cardiac surgery
Introduction: Metastatic tumors are the most frequent tumors of the heart with the melanoma metastasis being the most frequent. In cases of a cardiac tamponade or a low cardiac output syndrome due to the position of the tumor it could lead to an acute life-threatening condition for the patient.
Case report: We present a case of a successfully treated metastatic cardiac melanoma in a lifesaving cardiac surgery. A 42-year-old woman was admitted to the emergency department of the Clinical Center of Serbia in a critical state with signs of tricuspid orifice obstruction with a tumor mass. Her previous medical history showed that she had an adequate surgical excision of the melanoma in the right lumbar region at the age of 39. An emergency cardiac surgery was performed with the resection of the tumor and the atrial wall. The postoperative course was uneventful and a HP exam once again confirmed the same type of melanoma as previously diagnosed. The patient was alive and well on follow-up exams for 4 months when she was diagnosed with metastatic tumor masses in the pelvis with ascites and melanosis of the entire skin followed by lethal outcome 5 months after the cardiac surgery.
Conclusion: Surgical resection of metastatic cardiac melanoma can be safe and effective in an emergency scenario, especially in the case of solitary metastasis. It can be performed with excellent results and very few postoperative complications. However, due to the nature of the principal disease, the long-term survival rate remains low, giving the surgery a place in palliative treatment.
Aerts BRJ, Kock MCJM, Kofflard MJM, Plaisier PW. 2014. Cardiac metastasis of malignant melanoma: a case report. Neth Heart J 22:39-41.
Eggermont AM, Suciu S, Rutkowski P, et al. 2013. Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial. J Clin Oncol 31:3831-7.
Gibbs P, Cebon JS, Calafiore P, Robinson WA. 1999. Cardiac metastases from malignant melanoma. Cancer 85:78-84.
Glancy DL, Roberts WC. 1968. The heart in malignant melanoma. A study of 70 autopsy cases. Am J Cardiol 21:555-71.
Houmsse M, Raman SV, Leier CV, Orsinelli DA. 2004. Metastatic melanoma of the left ventricle: cardiac imaging in the diagnosis and surgical approach. Int J Cardiovasc Imaging 20:523-6; discussion 527-8.
Judge JM, Tillou JD, Slingluff Jr CL, Kern JA, Kron IL, Weiss GR. 2013. Surgical management of the patient with metastatic melanoma to the heart. J Card Surg 28:124-8.
Kontozis L, Soteriou M, Papamichael D, et al. 2011. Isolated right atrial metastasis of malignant melanoma mimicking a myxoma. Hellenic J Cardiol 52:281-4.
Magnuson WJ, Halligan JB. 2010. Successful treatment of melanoma metastatic to the left atrium using external beam radiation therapy. Oncology (Williston Park) 24:650-3.
Manola J, Atkins M, Ibrahim J, Kirkwood J. 2000. Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials. J Clin Oncol 18:3782-93.
Middleton MR, Grob JJ, Aaronson N, et al. 2000. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 18:158-66.
Mousseaux E, Meunier P, Azancott S, Dubayle P, Gaux JC. 1998. Cardiac metastatic melanoma investigated by magnetic resonance imaging. Magn Reson Imaging 16:91-5.
Morosin M, Azzu A, Capoccia M, Rosendahl U. 2019. Extensive cardiac infiltrative melanoma. J Card Surg 34:858-9.
Obeid AI, al Mudamgha A, Smulyan H. 1993. Diagnosis of right atrial mass lesions by transesophageal and transthoracic echocardiography. Chest 103:1447-51.
Onan B, Onan IS, Polat B. 2010. Surgical resection of solitary metastasis of malignant melanoma to the right atrium. Tex Heart Inst J 37:598-601.
Ozyuncu N, Sahin M, Altin T, Karaoguz R, Guldal M, Akyurek O. 2006. Cardiac metastasis of malignant melanoma: a rare cause of complete atrioventricular block. Europace 8:545-8.
Safa H, Glitza Oliva IC. 2019. Cardiac metastases in melanoma. N Engl J Med 380:858.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).